Exact Mass: 665.1580262000001

Exact Mass Matches: 665.1580262000001

Found 31 metabolites which its exact mass value is equals to given mass value 665.1580262000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

1,4-Dihydronicotinamide adenine dinucleotide

Dihydronicotinamide-adenine dinucleotide

C21H29N7O14P2 (665.1247674)


Nicotinamide adenine dinucleotide (NAD) is a coenzyme central to metabolism. Found in all living cells, NAD is called a dinucleotide because it consists of two nucleotides joined through their phosphate groups. One nucleotide contains an adenine nucleobase and the other nicotinamide. NAD exists in two forms: an oxidized and reduced form, abbreviated as NAD+ and NADH (H for hydrogen) respectively. NADH is the reduced form of NAD+, and NAD+ is the oxidized form of NADH. NAD (or nicotinamide adenine dinucleotide) is used extensively in glycolysis and the citric acid cycle of cellular respiration. The reducing potential stored in NADH can be either converted into ATP through the electron transport chain or used for anabolic metabolism. ATP "energy" is necessary for an organism to live. Green plants obtain ATP through photosynthesis, while other organisms obtain it via cellular respiration. NAD is a coenzyme composed of ribosylnicotinamide 5-diphosphate coupled to adenosine 5-phosphate by a pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). NADP is formed through the addition of a phosphate group to the 2 position of the adenosyl nucleotide through an ester linkage. NADH is the reduced form of NAD+, and NAD+ is the oxidized form of NADH, A coenzyme composed of ribosylnicotinamide 5-diphosphate coupled to adenosine 5-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). It forms NADP with the addition of a phosphate group to the 2 position of the adenosyl nucleotide through an ester linkage.(Dorland, 27th ed) [HMDB]. NADH is found in many foods, some of which are dill, ohelo berry, fox grape, and black-eyed pea. Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-hydro-beta-NAD

1,2-Dihydro-beta-NAD

C21H29N7O14P2 (665.1247674)


An NADP obtained by formal reduction of the 1,2-position in the pyridine ring of beta-NAD.

   

6-hydro-beta-NAD

1,6-Dihydro-beta-NAD

C21H29N7O14P2 (665.1247674)


An NADP obtained by formal reduction of the 1,6-position in the pyridine ring of beta-NAD.

   
   

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-bata-D-galactopyranoside]

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-bata-D-galactopyranoside]

C30H33O17 (665.1717668000001)


   

NADH

beta-nicotinamide adenine Dl-nucleotide ,reduced dipotassium salt

C21H29N7O14P2 (665.1247674)


A coenzyme found in all living cells; consists of two nucleotides joined through their 5-phosphate groups, with one nucleotide containing an adenine base and the other containing nicotinamide. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-beta-D-galactopyranoside]

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-beta-D-galactopyranoside]

C30H33O17 (665.1717668000001)


   
   
   
   
   

[[(2R,3S,4R,5R)-5-(5-acetyl-2,5-dihydropyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

[[(2R,3S,4R,5R)-5-(5-acetyl-2,5-dihydropyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

C22H31N6O14P2+ (665.1373426)


   

S-methyl 5-hydroxy-6-[4-hydroxy-6-(5-hydroxy-6-methoxy-1H-indole-2-carbonyl)-3,6-dihydropyrrolo[3,2-e]indole-2-carbonyl]-4-methoxy-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carbothioate

S-methyl 5-hydroxy-6-[4-hydroxy-6-(5-hydroxy-6-methoxy-1H-indole-2-carbonyl)-3,6-dihydropyrrolo[3,2-e]indole-2-carbonyl]-4-methoxy-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carbothioate

C34H27N5O8S (665.1580262000001)


   

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-bata-D-galactopyranoside]

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-bata-D-galactopyranoside]

C30H33O17+ (665.1717668000001)


   

N-acetyl-beta-D-galactosaminyl-(1->6)-[6-O-sulfonato-beta-D-glucosyl-(1->3)]-N-acetyl-beta-D-galactosamine

N-acetyl-beta-D-galactosaminyl-(1->6)-[6-O-sulfonato-beta-D-glucosyl-(1->3)]-N-acetyl-beta-D-galactosamine

C22H37N2O19S- (665.1711152)


   

6-[(2Z)-2-[(Z)-3-[3-(5-carboxypentyl)-6-sulfo-1,3-benzoxazol-3-ium-2-yl]prop-2-enylidene]-6-sulfo-1,3-benzoxazol-3-yl]hexanoic acid

6-[(2Z)-2-[(Z)-3-[3-(5-carboxypentyl)-6-sulfo-1,3-benzoxazol-3-ium-2-yl]prop-2-enylidene]-6-sulfo-1,3-benzoxazol-3-yl]hexanoic acid

C29H33N2O12S2+ (665.1474838000001)


   
   

YTM-T

YTM-T

C34H27N5O8S (665.1580262000001)


A member of the class of pyrroloindoles that is an intermediate in the biosynthesis of yatakemycin by Streptomyces sp. TP-A0356

   

Mesdopetam (hemitartrate)

Mesdopetam (hemitartrate)

C12H18FNO3S.1/2C4H6O6 (665.1155746000001)


Mesdopetam (IRL790) hemitartrate is a dopamine D3 receptor antagonist (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor) with psychomotor stabilizing properties. Mesdopetam hemitartrate is used for the research of motor and psychiatric complications in Parkinson disease[1][2].

   

5-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[3-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-2,3-dihydroindole-2-carboxylic acid

5-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[3-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-2,3-dihydroindole-2-carboxylic acid

C30H35NO16 (665.1955750000001)


   

3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}-3-{[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}-3-{[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

[C30H33O17]+ (665.1717668000001)


   

(13r,16r,19s,22r)-16-benzyl-19-[(2s)-butan-2-yl]-22-methyl-3,7,11,24-tetrathia-15,18,21,26,27,28,29-heptaazapentacyclo[21.2.1.1²,⁵.1⁶,⁹.1¹⁰,¹³]nonacosa-1(25),2(29),4,6(28),8,10(27),14,17,20,23(26)-decaene-14,17,20-triol

(13r,16r,19s,22r)-16-benzyl-19-[(2s)-butan-2-yl]-22-methyl-3,7,11,24-tetrathia-15,18,21,26,27,28,29-heptaazapentacyclo[21.2.1.1²,⁵.1⁶,⁹.1¹⁰,¹³]nonacosa-1(25),2(29),4,6(28),8,10(27),14,17,20,23(26)-decaene-14,17,20-triol

C30H31N7O3S4 (665.1371136)


   

1-[(2r,3r,4s,5r)-5-{[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4h-pyridine-3-carboximidic acid

1-[(2r,3r,4s,5r)-5-{[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4h-pyridine-3-carboximidic acid

C21H29N7O14P2 (665.1247674)


   

(2s)-5-hydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2e)-3-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-2,3-dihydroindole-2-carboxylic acid

(2s)-5-hydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2e)-3-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-2,3-dihydroindole-2-carboxylic acid

C30H35NO16 (665.1955750000001)


   

16-benzyl-22-methyl-19-(sec-butyl)-3,7,11,24-tetrathia-15,18,21,26,27,28,29-heptaazapentacyclo[21.2.1.1²,⁵.1⁶,⁹.1¹⁰,¹³]nonacosa-1(25),2(29),4,6(28),8,10(27),14,17,20,23(26)-decaene-14,17,20-triol

16-benzyl-22-methyl-19-(sec-butyl)-3,7,11,24-tetrathia-15,18,21,26,27,28,29-heptaazapentacyclo[21.2.1.1²,⁵.1⁶,⁹.1¹⁰,¹³]nonacosa-1(25),2(29),4,6(28),8,10(27),14,17,20,23(26)-decaene-14,17,20-triol

C30H31N7O3S4 (665.1371136)


   

(2r)-5-hydroxy-6-{[(2s,3s,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2e)-3-(4-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-2,3-dihydroindole-2-carboxylic acid

(2r)-5-hydroxy-6-{[(2s,3s,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2e)-3-(4-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-2,3-dihydroindole-2-carboxylic acid

C30H35NO16 (665.1955750000001)


   

1-[(2r,3s,4r,5r)-5-{[({[(2s,3s,4s,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4h-pyridine-3-carboximidic acid

1-[(2r,3s,4r,5r)-5-{[({[(2s,3s,4s,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4h-pyridine-3-carboximidic acid

C21H29N7O14P2 (665.1247674)